Since there wasn’t enough news this week for a SynBioBeta Weekly Wrap I thought we could dive into a unique technology platform that reached two important milestones in early June. Deinove may be unknown to many in the synthetic biology community (it’s based in France), but the industrial biotech is pioneering a platform capable of producing ethanol, enzymes, antibiotics, chemical intermediates, and other green chemicals from processed biomass feedstocks without additives (enzymes, yeast, antibiotics). What is the secret to the platform’s envious potential? Deinove has harnessed the unique capabilities of Deinococcus bacteria, most of which evolved to survive the harsh conditions of Earth 3.5 billion years ago. That’s sure to translate to robust industrial performance.